Pro Medicus (OTCMKTS:PMCUF) Shares Gap Down – Here’s What Happened

Pro Medicus Limited (OTCMKTS:PMCUFGet Free Report)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $134.8044, but opened at $125.90. Pro Medicus shares last traded at $125.90, with a volume of 10 shares.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group downgraded shares of Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, Pro Medicus presently has an average rating of “Hold” and a consensus target price of $155.00.

Check Out Our Latest Report on Pro Medicus

Pro Medicus Stock Performance

The company has a market cap of $13.15 billion and a PE ratio of 9,666.67. The company has a 50 day simple moving average of $116.44 and a two-hundred day simple moving average of $107.60.

Pro Medicus Company Profile

(Get Free Report)

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.

See Also

Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.